36 employees
Alcyone Therapeutics is Pioneering Next-Generation Precision CNS Genetic Therapies to unlock new possibilities
2010
$23M
from 1 investors over 1 rounds
Alcyone Lifesciences, Inc. raised $23M on June 9, 2021
Investors: RTW Investments, LP